Metraipolis › archive › dc_cfc4682ba420

Soluble B-Cell Maturation Antigen as a Prognostic Marker for Progression-Free Survival in Multiple Myeloma Treated with BCMA-Directed Therapies: A Systematic… — Europe PMC PMID:41749939

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41749939
DOI
10.3390/cancers18040686
License (as archived)
solo-consultazione
Archived
2026-11-05T15:27:49.990Z
SHA-256 of the archived text
45f28b063e42f89deae9a55212894b335f726220de6b58e58a19a416203753a4
Stable URL of this page
https://metraipolis.com/documento/dc_cfc4682ba420

How to cite

Soluble B-Cell Maturation Antigen as a Prognostic Marker for Progression-Free Survival in Multiple Myeloma Treated with BCMA-Directed Therapies: A Systematic… — Europe PMC PMID:41749939 — Europe PMC (en), https://europepmc.org/article/MED/41749939 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cfc4682ba420 (Metraipolis archive dc_cfc4682ba420, sha256 45f28b063e42f89deae9a55212894b335f726220de6b58e58a19a416203753a4)
BibTeX
@misc{dccfc4682ba420,
  title = {Soluble B-Cell Maturation Antigen as a Prognostic Marker for Progression-Free Survival in Multiple Myeloma Treated with BCMA-Directed Therapies: A Systematic… — Europe PMC PMID:41749939},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41749939},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cfc4682ba420; sha256 45f28b063e42f89deae9a55212894b335f726220de6b58e58a19a416203753a4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41749939. Agents can read the archived copy with the MCP tool read_document.